NS
AGIO icon

NBC Securities’s Agios Pharmaceuticals AGIO Stock Holding History

NBC Securities’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-241
Closed -$9.67K – 2789
2025
Q3 		$9.67K Sell
241
-104
-30% -$3.91K ﹤0.01% 2023
2025
Q2 		$11K Hold
345
– – ﹤0.01% 1911
2025
Q1 		$10K Buy
+345
New +$11.4K ﹤0.01% 1717
2024
Q4 		– Sell
-345
Closed -$15K – 1261
2024
Q3 		$15K Buy
345
+55
+19% +$2.5K ﹤0.01% 1598
2024
Q2 		$12K Hold
290
– – ﹤0.01% 1610
2024
Q1 		$8K Buy
+290
New +$7.76K ﹤0.01% 1754

Other funds holding AGIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return

NBC Securities's AGIO Position: Q4 2025 in Review

NBC Securities sold out of Agios Pharmaceuticals (AGIO) in Q4 2025, closing a stake of 241 shares — an estimated $9.67K sold.

NBC Securities first reported a position in AGIO in Q1 2024 and held it in 6 quarters. The position peaked at $15K in Q3 2024. 238 funds tracked by Wall St. Rank hold AGIO as of Q4 2025.

  • NBC Securities reported no remaining Agios Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • NBC Securities sold 241 Agios Pharmaceuticals shares in Q4 2025, an estimated $9.67K.
  • NBC Securities first reported a position in Agios Pharmaceuticals in Q1 2024 and held it in 6 quarters.
  • NBC Securities's Agios Pharmaceuticals position peaked at $15K in Q3 2024.
  • 238 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q4 2025.

Based on NBC Securities's 13F filing for Q4 2025, filed 29 Jan 2026.